Fibronectin

被引:142
作者
Romberger, DJ
机构
[1] Department of Internal Medicine, Pulmon. and Critical Care Med. Sect., Omaha, NE 68198-5300
关键词
extracellular matrix; fibronectin; cell-cell interactions; mRNA splicing;
D O I
10.1016/S1357-2725(96)00172-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibronectin is a glycoprotein consisting of repeating units of amino acids, which form domains that enable the molecule to interact with a variety of cells through both integrin and non-integrin receptors. It is encoded by a single gene, but alternative splicing of pre-mRNA allows formation of multiple isoforms that have critical roles in cell adhesion, migration and proliferation. The essential nature of fibronectin in development has clearly been demonstrated in a ''knock-out'' mouse model in which early lethality occurs. Fibronectin influences diverse processes including inflammation, wound repair, malignant metastasis, microorganism attachment and thrombosis. Researchers are currently developing tools, including synthetic peptides based on specific fibronectin regions. These molecules have been shown to alter processes such as lymphocyte binding in synovial tissue of rheumatoid arthritis, coronary arteriopathy in animal models of cardiac transplantation, and platelet aggregation in patients, and are thus providing important new therapeutic possibilities.
引用
收藏
页码:939 / 943
页数:5
相关论文
共 17 条
[1]   Adhesion mediated by fibronectin's alternatively spliced ED(b) (EIIIB) and its neighboring type III repeats [J].
Chen, WS ;
Culp, LA .
EXPERIMENTAL CELL RESEARCH, 1996, 223 (01) :9-19
[2]   FURTHER-STUDIES ON CYCLIC RGD ANALOGS [J].
DAVIES, JS ;
ENJALBAL, C ;
WISE, C ;
JONES, G ;
HANDA, BK .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1994, 22 (04) :1049-1052
[3]   EXPRESSION AND FUNCTIONAL-SIGNIFICANCE OF ALTERNATIVELY SPLICED CS1 FIBRONECTIN IN RHEUMATOID-ARTHRITIS MICROVASCULATURE [J].
ELICES, MJ ;
TSAI, V ;
STRAHL, D ;
GOEL, AS ;
TOLLEFSON, V ;
ARRHENIUS, T ;
WAYNER, EA ;
GAETA, FCA ;
FIKES, JD ;
FIRESTEIN, GS .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :405-416
[4]  
FRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261
[5]   NOVEL ANTIPLATELET THERAPIES FOR TREATMENT OF PATIENTS WITH ISCHEMIC-HEART-DISEASE - INHIBITORS OF THE PLATELET GLYCOPROTEIN IIB/IIIA INTEGRIN RECEPTOR [J].
FRISHMAN, WH ;
BURNS, B ;
ATAC, B ;
ALTURK, N ;
ALTAJAR, B ;
LERRICK, K .
AMERICAN HEART JOURNAL, 1995, 130 (04) :877-892
[6]  
GEORGE EL, 1993, DEVELOPMENT, V119, P1079
[7]  
Hynes R. O., 1990, SPRINGER SERIES MOL, P1
[8]   FIBRONECTIN - A VERSATILE MATRIX PROTEIN WITH ROLES IN THORACIC DEVELOPMENT, REPAIR AND INFECTION [J].
LIMPER, AH ;
ROMAN, J .
CHEST, 1992, 101 (06) :1663-1673
[9]   THE MATRIX-DEGRADING METALLOPROTEINASES [J].
MATRISIAN, LM .
BIOESSAYS, 1992, 14 (07) :455-463
[10]   BLOCKADE OF VERY LATE ANTIGEN-4 INTEGRIN BINDING TO FIBRONECTIN WITH CONNECTING SEGMENT-1 PEPTIDE REDUCES ACCELERATED CORONARY ARTERIOPATHY IN RABBIT CARDIAC ALLOGRAFTS [J].
MOLOSSI, S ;
ELICES, M ;
ARRHENIUS, T ;
DIAZ, R ;
COULBER, C ;
RABINOVITCH, M .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2601-2610